Plasma nitric oxide before and after smoking cessation with nicotine nasal spray

Journal of Clinical Pharmacology

Volumn 38, Issue 1, 1998, Pages 22-27

  Miller, Virginia M ^a   Lewis, Debra A ^a   Rud, Kevin S ^a   Offord, Kenneth P ^a   Croghan, Ivana T ^a   Hurt, Richard D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NEUROTRANSMITTER; NICOTINE; NITRIC OXIDE; NOSE SPRAY;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG SELF ADMINISTRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; SMOKING CESSATION;

EID: 0031933514     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04371.x     Document Type: Article

References (33)

1. Jonas MA, Oates JA, Ockene JK, Hannekens CH: Statement on smoking and cardiovascular disease for health care professionals. Circulation 1992;86:1664-1669.
2. Beard CM, Kottke TE, Armegers JF, Ballard DJ: The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40-to 59-year-old women, 1960 through 1982. Mayo Clin Proc 1989;64:1471-1480.
3. Hjalmarson A, Franzon M, Westin A, Wiklund O: Effect of nicotine nasal spray on smoking cessation. Arch Intern Med 1994;154:2567-2572.
4. Sutherland G, Stapleton JA, Russell MA, Jarvis MH, Hajek P, Belcher M, et al: Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-329.
5. Von Der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, et al: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of enriothelial cell nitric oxide synthase gene. Proc Natl Acad Sci 1995;92:1137-1141.
6. Davies MG, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen P: Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 1994;116:557-568.
7. Jungersten L, Edlund A, Petersson A: Wennmalm A. Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol 1996;16:369-379.
8. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y: Comparison of tests used to distinguish smokers from non-smokers. Am J Public Health 1987;77:1435-1438.
9. Machacek DA, Jiang NS: Quantification of cotinine in plasma and saliva by liquid chromatography. Clin Chem 1986;32:979-982.
10. Archer S: Measurement of nitric oxide in biological models. FASEB J 1993;7:349-360.
11. Braman RS, Hendrix SA: Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 1989;61:2715-2718.
12. Rangemark C, Wennmalm A: Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers. Clin Physiol 1996;16:301-315.
13. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 1990;87:1620-1624.
14. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H: Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-H880.
15. Deliconstantinos G, Villiotou V, Stavrides JC: Scavenging effects of hemoglobin and related heme containing compounds on nitric oxide, reactive oxidants and carcinogenic volatile nitroso-compounds of cigarette smoke: a new method for protection against the dangerous cigarette constituents. Anticancer Res 1994;14(6B):2717-2726.
16. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, et al: Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993;73:1121-1127.
17. Hurt RD, Dale LC, Croghan GA, Croghan IT, Gomez-Dalh L, Offord KP: Nicotine nasal spray for smoking cessation: use pattern, side effects, withdrawal symptom relief, and cotinine levels. Mayo Clin Proc (in press).
18. Benowitz NL, Jacob P III: Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-493.
19. Hurt RD, Dale LC, Offord KP, Lauger GG, Baskin LB, Lawson GM, et al: Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther 1993;54:98-106.
20. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR: High dose nicotine patch therapy: percent replacement and smoking cessation. JAMA 1995;274:1353-1358.
21. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Garth I, et al: Nitric oxide synthase isozymes characterization, purification, molecular cloning, and function. Hypertension 1994;23:1121-1131.
22. Loscalzo J, Welch G: Nitric oxide and its role in the cardiovascular system. Progress Cardiovasc Dis 1995;38:87-104.
23. Toda N, Kitamura Y, Okamura T: Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Physiol 1994;266:H1985-H1992.
24. Zeiher AM, Schachinger V, Minners J: Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-1100.
25. Jorge PA, Ozaki MR, Almeida EA: Endothelial dysfunction in coronary vessels and thoracic aorta of rats exposed to cigarette smoke. Clin Exp Pharmacol Physiol 1995;22:410-413.
26. Suzuki N, Ishii Y, Kitamura S: Effects of nicotine on production of endothelin and eicosanoid by bovine pulmonary artery endothelial cells. Prostagland Leukotrien Essen Fatty Acids 1994;50:193-197.
27. Jungersten L, Edlund A, Hafstrom LO, Karlsson L, Petersson A, Wennmalm A: Plasma nitrate as an index of immune system activation in animals and man. J Clin Lab Immunol 1993;40:1-4.
28. Bassenge E: Holtz J, Strohschein H. Sympathoadrenal activity and sympathoinhibitory hormones during acute and chronic nicotine application in dogs. Klin Wochenschr 1988;66(Suppl 11):12-20.
29. Holtz J, Sommer O, Bassenge E. Development of specific tolerance to nicotine infusions in dogs on chronic nicotine treatment. Klin Wochenschr 1984;62(Suppl 2):51-57.
30. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW Jr: Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994;150:469-474.
31. Fagerstrom KO, Pomerleau O, Giordani B, Stelson F: Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 1994;116:117-119.
32. Green JT, Thomas GAO, Rhodes J, Evans BK, Russell MAH, Feyerabend C, et al. Pharmacokinetics of nicotine carbomer enemas: - a new treatment modality for ulcerative colitis. Clin Pharmacol Ther 1997;61:340-348.
33. Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, et al: Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126:364-371.